ICD's near end of life: Risk Versus Benefit- A Review

American Journal of Hospice and Palliative Medicine

Volumn 29, Issue 6, 2012, Pages 421-430

  Singh, Balraj ^a   Singh, Jasmeet ^b  

^a East Tennessee State University   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

activities of daily living; arrhythmias; death; defibrillator; hospice; ICD; implantable; interventions; QoL; randomized clinical trials; SCD

Indexed keywords

ARTICLE; ETHICS; HEART ARRHYTHMIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; PSYCHOLOGY; QUALITY OF LIFE; RISK ASSESSMENT; TERMINAL CARE;

ARRHYTHMIAS, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; HUMANS; PSYCHOLOGY; QUALITY OF LIFE; RISK ASSESSMENT; TERMINAL CARE;

EID: 84865080084     PISSN: 10499091     EISSN: None     Source Type: Journal    
DOI: 10.1177/1049909111432135     Document Type: Article

References (56)

1. Turakhia MP.Sudden cardiac death and implantable cardioverter-defibrillators.Am Fam Physician. 2010;82 (11): 1357-1366.
2. Pedersen SS,Sears SF,Burg MM,Van Den Broek KC.Does ICD indication affect quality of life and levels of distress?.Pacing Clin Electrophysiol. 2009;32 (2): 153-156.
3. Groeneveld PW,Matta MA,Suh JJ,Yang F,Shea JA.Quality of life among implantable cardioverter-defibrillator recipients in the primary prevention therapeutic era.Pacing Clin Electrophysiol. 2007;30 (4): 463-471.
4. Packer DL,Prutkin JM,Hellkamp AS, et al.Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial.Circulation Circulation. 2009 2010;120 121 (22(6)): 2170 e39-2106.
5. Epstein AE,DiMarco JP,Ellenbogen KA, et al.ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and anti-arrhythmia devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons [published correction appears in Circulation. 2009;120(5): e34-e35].Circulation. 2008;117 (21): e350-e408.
6. Salukhe TV,Briceno NI,Ferenczi EA,Sutton R,Francis DP.Is there benefit in implanting defibrillators in patients with severe heart failure?.Heart. 2010;96 (8): 599-603.
7. Bardy GH,Poole JE,Kudenchuk PJ,Dolack GL,Kelso D,Mitchell R.A prospective randomized repeat-crossover comparison of antitachycardia pacing with low-energy cardioversion.Circulation. 1993;87 (6): 1889-1896.
8. http://www.nhlbi.nih.gov/health/dci/Diseases/icd/icd_whatis.html.
9. Karin KM,Di Biase L,Pieragnoli P, et alPacemakers and Implantable Cardioverter Defibrillator. Ahmad ALEllenbogen KANatale AWang PJ, ed.
10. Pinski SL,Trohman RG.Interference in implanted cardiac devices, Part I.Pacing Clin Electrophysiol. 2002;25 (9): 1367-1381.
11. Pinski SL,Trohman RG.Interference in implanted cardiac devices, part II.Pacing Clin Electrophysiol. 2002;25 (10): 1496-1509.
12. Madigan JD,Choudhri AF,Chen J,Spotnitz HM,Oz MC,Edwards N.Surgical management of the patient with an implanted cardiac device: implications of electromagnetic interference.Ann Surg. 1999;230 (5): 63-47.
13. Hudson F,Coulshed D,D'Souza E,Baker C.Effect of radiation therapy on the latest generation of pacemakers and implantable cardioverter defibrillators: a systematic review.J Med Imaging RadiatOncol. 2010;54 (1): 53-61.
14. Roedig JJ,Shah J,Elayi CS,Miller CS.Interference of cardiac pacemaker and implantable cardioverter-defibrillator activity during electronic dental device use.J Am Dent Assoc. 2010;141 (5): 521-526.
15. Sher NA,Golben MP,Kresge K,Selznick L,Adabag S.An in vitro evaluation of electromagnetic interference between implantable cardiac devices and ophthalmic laser systems.Europace. 2011;13 (4): 583-588.
16. Ding L,Hua W,Niu H,Chen K,Zhang S.Primary prevention of sudden cardiac death using implantable cardioverter defibrillators.Europace. 2008;10 (9): 1034-1041.
17. Buxton AE,Lee KL,Fisher JD,Josephson ME,Prystowsky EN,Hafley G.A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter unsustained tachycardia trial investigators.N Engl J Med N Engl J Med. 1999 2000;341 342 (25(17)): 1882 1300-1890.
18. Moss AJ,Zareba W,Hall WJ, et al.Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.N Engl J Med. 2002;346 (12): 877-883.
19. Wever EF,Hauer RN,van Capelle FL, et al.Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors.Circulation. 1995;91 (8): 2195-2203.
20. Siebels J,Kuck KH.Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg).Am Heart J. 1994;127 ((4 pt 2)): 1139-1144.
21. Connolly SJ,Gent M,Roberts RS, et al.Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone.Circulation. 2000;101 (11): 1297-1302.
22. Kuck KH,Cappato R,Siebels J,Rüppel R.Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH).Circulation. 2000;102 (7): 748-754.
23. Connolly SJ,Hallstrom AP,Cappato R, et al.Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs. Implantable Defibrillator study. cardiac arrest study hamburg. Canadian implantable defibrillator study.Eur Heart J. 2000;21 (24): 2071-2078.
24. Bardy GH,Lee KL,Mark DB, et al.Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.N Engl J Med N Engl J Med. 2005 2005;352 352 (3 (20)): 225 2146-237.
25. Kadish A,Dyer A,Daubert JP, et al.Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.N Engl J Med. 2004;350 (21): 2151-2158.
26. Desai AS,Fang JC,Maisel WH,Baughman KL.Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials.JAMA. 2004;292 (23): 2874-2879.
27. Moss AJ,Hall WJ,Cannom DS, et al.Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter automatic defibrillator implantation trial investigators.N Engl J Med. 1996;335 (26): 1933-1940.
28. Zareba W,Moss AJ,Daubert JP,Hall WJ,Robinson JL,Andrews M.Implantable cardioverter defibrillator in high-risk long QT syndrome patients.J Cardiovasc Electrophysiol. 2003;14 (4): 337-341.
29. Viskin S.Implantable cardioverter defibrillator in high-risk long QT syndrome patients.J Cardiovasc Electrophysiol. 2003;14 (10): 1130-1131.
30. Mönnig G,Köbe J,Löher A, et al.Implantable cardioverter-defibrillator therapy in patients with congenital long-QT syndrome: a long-term follow-up.Heart Rhythm. 2005;2 (5): 497-504.
31. Hobbs JB,Peterson DR,Moss AJ, et al.Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome.JAMA. 2006;296 (10): 1249-1254.
32. Tsai FS,Aronow WS,Devabhaktuni S, et al.Prevalence of complications during implantation and during 38-month follow-up of 1060 consecutive patients with implantable cardioverter-defibrillators.Am J Ther. 2010;17 (1): e8-e10.
33. Eckstein J,Koller MT,Zabel M, et al.Necessity for surgical revision of defibrillator leads implanted long-term: causes and management.Circulation. 2008;117 (21): 2727-2733.
34. Grimm W,Flores BF,Marchlinski FE.Electrocardiographically documented unnecessary, spontaneous shocks in 241 patients with implantable cardioverter defibrillators.Pacing Clin Electrophysiol. 1992;15 ((11 pt 1)): 1667-1673.
35. Schliamser JE,Avramovitch NA,Karkabi B,Flugelman MY,Militianu A,Lewis BS.Rhabdomyolysis induced by repeated internal cardioverter defibrillator discharges.Pacing Clin Electrophysiol. 2002;25 ((4 pt 1)): 516-517.
36. Krahn AD,Lee DS.Birnie D,et al;for the Ontario ICD Database Investigators. Predictors of short-term complications after implantable cardioverter-defibrillator replacement: results from the ontario ICD database.Circ Arrhythm Electrophysiol. 2011;4 (2): 136-142.
37. Goldstein N,Carlson M,Livote E,Kutner JS.Brief communication: management of implantable cardioverter-defibrillators in hospice: a nationwide survey.Ann Intern Med. 2010;152 (5): 296-299.
38. Goldstein NE,Lampert R,Bradley EH,Lynn J,Krumholz HM.Management of implantable cardioverter defibrillators in end-of-life care.Ann Intern Med. 2004;141 (11): 835-838.
39. Sears SF,Todaro JF,Lewis TS,Sotile W,Conti JB.Examining the psychosocial impact of implantable cardioverter defibrillators: a literature review.Clin Cardiol. 1999;22 (7): 481-489.
40. Morrison LJ,Calvin AO,Nora H,Porter Storey C.Managing cardiac devices near the end of life: a survey of hospice and palliative care providers.Am J Hosp Palliat Care. 2010;27 (8): 545-551.
41. Sears SF,Lewis TS,Kuhl EA,Conti JB.Predictors of quality of life in patients with implantable cardioverter defibrillators.Psychosomatics. 2005;46 (5): 451-457.
42. Sears SF,Todaro JF,Urizar G, et al.Assessing the psychosocial impact of the ICD: a national survey of implantable cardioverter defibrillator health care providers.Pacing Clin Electrophysiol. 2000;23 (6): 939-945.
43. Traub D,Ganz L.Implantable cardioverter-defibrillators for secondary prevention: is it worth it in the elderly?.Am J Geriatr Cardiol. 2006;15 (2): 93 100-99 101.
44. Badger JM,Morris PL.Observations of a support group for automatic implantable cardioverter-defibrillator recipients and their spouses.Heart Lung. 1989;18 (3): 238-243.
45. Fitchet A,Doherty PJ,Bundy C,Bell W,Fitzpatrick AP,Garratt CJ.Comprehensive cardiac rehabilitation programme for implantable cardioverter-defibrillator patients: a randomised controlled trial.Heart. 2003;89 (2): 155-160.
46. Frizelle DJ,Lewin RJ,Kaye G, et al.Cognitive-behavioural rehabilitation programme for patients with an implanted cardioverter defibrillator: a pilot study.Br J Health Psychol. 2004;9 (pt 3): 381-392.
47. Kohn CS,Petrucci RJ,Baessler C,Soto DM,Movsowitz C.The effect of psychological intervention on patients' long-term adjustment to the ICD: a prospective study.Pacing Clin Electrophysiol. 2000;23 ((4 pt 1)): 450-456.
48. Dougherty CM,Lewis FM,Thompson EA,Baer JD,Kim W.Short-term efficacy of a telephone intervention by expert nurses after an implantable cardioverter defibrillator.Pacing Clin Electrophysiol. 2004;27 (12): 1594-1602.
49. Kapa S,Mueller PS,Hayes DL,Asirvatham SJ.Perspectives on withdrawing pacemaker and implantable cardioverter-defibrillator therapies at end of life: results of a survey of medical and legal professionals and patients.Mayo Clin Proc. 2010;85 (11): 981-990.
50. Harrington MD,Luebke DL,Lewis WR,Aulisio MP,Johnson NJ.Cardiac pacemakers at end of life #111.J PalliatMed. 2005;8 (5): 1055-1056.
51. Conelius J.A literature review: advance directives and patients with implantable cardioverter defibrillators.J Am Acad Nurse Pract. 2010;22 (5): 250-255.
52. Lampert R,Hayes DL,Annas GJ, et al.American College of Cardiology; American Geriatrics Society; American Academy of Hospice and Palliative Medicine, American Heart Association; European Heart Rhythm Association; Hospice and Palliative Nurses Association. HRS expert consensus statement on the management of cardiovascular implantable electronic devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy.Heart Rhythm. 2010;7 (7): 1008-1026.
53. Sears SF,Matchett M,Conti JB.Effective management of ICD patient psychosocial issues and patient critical events.J Cardiovasc Electrophysiol. 2009;20 (11): 1297-1304.
54. Kramer DB,Kesselheim AS,Brock DW,Maisel WH.Ethical and legal views of physicians regarding deactivation of cardiac implantable electrical devices: a quantitative assessment.Heart Rhythm. 2010;7 (11): 1537-1542.
55. Lewis WR,Luebke DL,Johnson NJ,Harrington MD,Costantini O,Aulisio MP.Withdrawing implantable defibrillator shock therapy in terminally ill patients.Am J Med. 2006;119 (10): 892-896.
56. Ladwig KH,Ischinger NF,Ronel J,Kolb C.Treating ICD patients at the end of their lives: attitudes, knowledge, and behavior of doctors and patients: A critical literature analysis.Herzschrittmacherther Elektrophysiol. 2011;22 (3): 151-6.